BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19913895)

  • 1. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.
    Liao SY; Darcy KM; Randall LM; Tian C; Monk BJ; Burger RA; Fruehauf JP; Peters WA; Stock RJ; Stanbridge EJ
    Gynecol Oncol; 2010 Mar; 116(3):452-8. PubMed ID: 19913895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
    Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
    Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix.
    Mayer A; Höckel M; Vaupel P
    Clin Cancer Res; 2005 Oct; 11(20):7220-5. PubMed ID: 16243791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
    Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
    Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
    Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
    Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
    Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
    Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
    Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
    Kim SJ; Rabbani ZN; Dewhirst MW; Vujaskovic Z; Vollmer RT; Schreiber EG; Oosterwijk E; Kelley MJ
    Lung Cancer; 2005 Sep; 49(3):325-35. PubMed ID: 15935515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
    J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
    Loncaster JA; Harris AL; Davidson SE; Logue JP; Hunter RD; Wycoff CC; Pastorek J; Ratcliffe PJ; Stratford IJ; West CM
    Cancer Res; 2001 Sep; 61(17):6394-9. PubMed ID: 11522632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
    Betof AS; Rabbani ZN; Hardee ME; Kim SJ; Broadwater G; Bentley RC; Snyder SA; Vujaskovic Z; Oosterwijk E; Harris LN; Horton JK; Dewhirst MW; Blackwell KL
    Br J Cancer; 2012 Feb; 106(5):916-22. PubMed ID: 22333602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
    J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.
    Kyndi M; Sørensen FB; Knudsen H; Alsner J; Overgaard M; Nielsen HM; Overgaard J;
    Breast Cancer Res; 2008; 10(2):R24. PubMed ID: 18355402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
    Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
    Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
    Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
    Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer.
    Woelber L; Kress K; Kersten JF; Choschzick M; Kilic E; Herwig U; Lindner C; Schwarz J; Jaenicke F; Mahner S; Milde-Langosch K; Mueller V; Ihnen M
    BMC Cancer; 2011 Jan; 11():12. PubMed ID: 21223596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.